WHO ICTRP trial

A clinical trial to study the effects of two drugs, prasugrel and clopidogrel in…

CTRI/2009/091/000571 · Clinical Trials Registry India (CTRI) · Not Recruiting

Key facts

Trial ID CTRI/2009/091/000571
Public title A clinical trial to study the effects of two drugs, prasugrel and clopidogrel in patients with acute coronary syndrome who are to undergo percutaneous intervention
Scientific title A prospective, randomised, double-blind, double dummy, comparative, parallel assignment, multicentric clinical trial to compare the safety and efficacy of Prasugrel vs. Clopidogrel in patients with moderate-to-high-risk Acute Coronary Syndromes who are to undergo Percutaneous Coronary Intervention…
Primary sponsor TORRENT PHARMACEUTICALS LIMITED
Registry Clinical Trials Registry India (CTRI)
Recruitment status Not Recruiting
Study type Interventional
Phase Phase 3
Countries India
Interventions Intervention1: Prasugrel: Loading Dose: 60mg, Maintenance dose: 10mg Control Intervention1: Clopidogrel: Loading dose:300mg, Maintenance Dose: 75mg
Registration date Jan 13, 2010
Target size 220
Secondary IDs CT/PRAS/ACS/09-01
Registry page ctri.nic.in

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations